At this year's American Society of Hematology conference in San Diego, MedShr founder Dr Asif Qasim presents a groundbreaking mobile-first medical education programme and its impact on SCD diagnosis and management in Kenya, Ghana, Zambia, Uganda, Tanzania and India.
Waystar has signed a definitive agreement to acquire Iodine Software, a $1.25 billion deal that seeks to empower healthcare payments with more AI capabilities.
Read more here.
Doctors will be able to prescribe a new treatment for people with inflammatory bowel disease (IBD), after the UK medicines watchdog approved guselkumab (Tremfya) for use on the NHS.
Read more here.